News

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the ...
In a clinical trial, the UTI drug gepotidacin cleared infections in 93% of cases, performing just as well as the current ...
About the expert Sasha Ross, DMD, MS, is a board-certified periodontist who has been with the Cleveland Clinic since 2013.
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today ...